Applies to bamlanivimab: intravenous solution.
Due to the high frequency of the Omicron BA.2 sub-variant, this drug is not currently authorized in any US region; therefore, this drug may not be administered for treatment of COVID-19 under the EUA until further notice by the US FDA.
Get emergency medical help if you have signs of an allergic reaction: hives, itching; difficult breathing; swelling of your face, lips, tongue, or throat.
Some side effects may occur during the injection. Tell your medical caregivers right away if you have:
-
throat irritation, swelling in your face or throat;
-
dizziness, a light-headed feeling (like you might pass out);
-
chest pain, wheezing, shortness of breath;
-
fever, chills, sweating, nausea;
-
fast or slow heartbeats, headache, pounding in your neck or ears;
-
weakness, tiredness;
-
a rash or itching; or
-
muscle pain.
Call your doctor if you have new or worsening symptoms after the infusion, such as fever, confusion, weakness, tiredness, trouble breathing, or fast or slow heartbeats.
Common side effects may include:
-
nausea;
-
dizziness; or
-
itching.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
